132 related articles for article (PubMed ID: 6585111)
1. Effects of carbenoxolone on gastric release of prostaglandin (PG)E2 in patients with peptic ulcer disease.
Rask-Madsen J; Bukhave K; Madsen PE; Bekker C
Acta Gastroenterol Belg; 1983; 46(9-10):419-28. PubMed ID: 6585111
[No Abstract] [Full Text] [Related]
2. Effect of carbenoxolone on gastric prostaglandin E2 levels in patients with peptic ulcer disease following vagal and pentagastrin stimulation.
Rask-Madsen J; Bukhave K; Madsen PE; Bekker C
Eur J Clin Invest; 1983 Aug; 13(4):351-6. PubMed ID: 6413222
[TBL] [Abstract][Full Text] [Related]
3. Gastric and systemic effects of carbenoxolone and its derivative ISF 2715 in humans.
Velo GP; Minuz P; Riela A; Brocco G; Degan M; Franco L; Cavallini G
Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():361-5. PubMed ID: 2959078
[No Abstract] [Full Text] [Related]
4. Carbenoxolone and prostaglandin E2 and F2 alpha gastric juice levels in man.
Minuz P; Cavallini G; Angelini GP; Lechi A; Brocco G; Riela A; Scuro LA; Velo GP
Pharmacol Res Commun; 1984 Sep; 16(9):875-84. PubMed ID: 6594711
[TBL] [Abstract][Full Text] [Related]
5. Carbenoxolone and deglycyrrhized liquorice have little or no effect on prostanoid synthesis by rat gastric mucosa ex vivo.
Bennett A; Melhuish PB; Stamford IF
Br J Pharmacol; 1985 Nov; 86(3):693-5. PubMed ID: 3840708
[TBL] [Abstract][Full Text] [Related]
6. Effect of carbenoxolone on prostaglandin synthesizing and metabolizing enzymes and correlation with gastric mucosal carbenoxolone concentrations.
Peskar BM
Scand J Gastroenterol Suppl; 1980; 65():109-14. PubMed ID: 6259713
[TBL] [Abstract][Full Text] [Related]
7. Effect of carbenoxolone on gastric prostaglandin E release and cytoprotection in the rat.
Martin A; Gurrieri G; Sturniolo GC; Naccarato R
Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():409-10. PubMed ID: 6221623
[No Abstract] [Full Text] [Related]
8. Generation of prostaglandins in gastric mucosa of patients with peptic ulcer disease: effect of nonsteroidal antiinflammatory compounds.
Konturek SJ; Obtulowicz W; Kwiecien N; Oleksy J
Scand J Gastroenterol Suppl; 1984; 101():75-7. PubMed ID: 6599541
[TBL] [Abstract][Full Text] [Related]
9. Effect of carbenoxolone on alkaline secretion by isolated amphibian gastric and duodenal mucosa.
Rees WD; Garner A; Heylings JR; Flemström G
Eur J Clin Invest; 1981 Dec; 11(6):481-6. PubMed ID: 6800823
[TBL] [Abstract][Full Text] [Related]
10. [Value of biogastrone and duodenal biogastrone in the treatment of peptic ulcer].
Stadnicki A
Pol Tyg Lek; 1979 Jun; 34(26):1029-31. PubMed ID: 503921
[No Abstract] [Full Text] [Related]
11. Effects of carbenoxolone and prostaglandin E2 on transmucosal potential difference in the rat stomach.
Watanabe K; Yano S; Yamaguchi T
Scand J Gastroenterol Suppl; 1989; 162():87-90. PubMed ID: 2595316
[TBL] [Abstract][Full Text] [Related]
12. Gastric gel mucus thickness: effect of distention, 16,16-dimethyl prostaglandin e2, and carbenoxolone.
Bickel M; Kauffman GL
Gastroenterology; 1981 Apr; 80(4):770-5. PubMed ID: 6162705
[TBL] [Abstract][Full Text] [Related]
13. Influence of 'cytoprotective' drugs (carbenoxolone, zolimidine, prostanoic acid) on mucus secretion in patients with gastric ulcer.
Parodi MC; Molinari F; Barocci S
Scand J Gastroenterol Suppl; 1984; 92():163-6. PubMed ID: 6234649
[TBL] [Abstract][Full Text] [Related]
14. Distribution of prostaglandin E2 in gastric and duodenal mucosa: possible role in the pathogenesis of peptic ulcer.
Park SM; Yoo BC; Lee HR; Chung H; Lee YS
Korean J Intern Med; 1992 Jan; 7(1):1-8. PubMed ID: 1477025
[TBL] [Abstract][Full Text] [Related]
15. Drug therapy for peptic ulcer: drugs that act on the gastric mucosa.
Kauffman GL
J Clin Gastroenterol; 1981; 3(Suppl 2):95-101. PubMed ID: 6119340
[TBL] [Abstract][Full Text] [Related]
16. [Prostaglandin and cyclic nucleotide levels in patients with peptic ulcer and chronic gastritis with secretory insufficiency].
Valenkevich LN; Zaĭchuk ASh
Ter Arkh; 1987; 59(2):29-31. PubMed ID: 3472366
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of leukotriene formation as a mode of action of gastroprotective drugs.
Lange K; Peskar BA; Peskar BM
Prog Clin Biol Res; 1987; 242():283-8. PubMed ID: 3671388
[No Abstract] [Full Text] [Related]
18. Carbenoxolone and incorporation of (3H) glucosamine into gastric mucosa.
Meek EM; Rhodes J; Mayberry JF
Curr Med Res Opin; 1978; 5(8):645-7. PubMed ID: 710177
[TBL] [Abstract][Full Text] [Related]
19. Effects of carbenoxolone on the gastric mucosal prostaglandin and thromboxane system.
Peskar BM
Acta Gastroenterol Belg; 1983; 46(9-10):429-36. PubMed ID: 6324520
[No Abstract] [Full Text] [Related]
20. [Endogenous prostaglandin E2 levels in the gastric mucosa of patients with stomach ulcer].
Rácz I; Téri N; Jávor T
Orv Hetil; 1986 May; 127(21):1247-51. PubMed ID: 3523372
[No Abstract] [Full Text] [Related]
[Next] [New Search]
